Cargando…

Metabolic Footprints and Molecular Subtypes in Breast Cancer

Cancer treatment options are increasing. However, even among the same tumor histotype, interpatient tumor heterogeneity should be considered for best therapeutic result. Metabolomics represents the last addition to promising “omic” sciences such as genomics, transcriptomics, and proteomics. Biochemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cappelletti, Vera, Iorio, Egidio, Miodini, Patrizia, Silvestri, Marco, Dugo, Matteo, Daidone, Maria Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757146/ https://www.ncbi.nlm.nih.gov/pubmed/29434411 http://dx.doi.org/10.1155/2017/7687851

Ejemplares similares

Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer
por: Callari, Maurizio, et al.
Publicado: (2018)

Prognostic and functional role of subtype‐specific tumor–stroma interaction in breast cancer
por: Merlino, Giuseppe, et al.
Publicado: (2017)

Stromal Activation by Tumor Cells: An in Vitro Study in Breast Cancer
por: Merlino, Giuseppe, et al.
Publicado: (2016)

Use of Formalin-Fixed Paraffin-Embedded Samples for Gene Expression Studies in Breast Cancer Patients
por: Musella, Valeria, et al.
Publicado: (2015)

miR-30e* is an independent subtype-specific prognostic marker in breast cancer
por: D'Aiuto, F, et al.
Publicado: (2015)

Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression
por: Cappelletti, Vera, et al.
Publicado: (2020)

Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients
por: Fina, Emanuela, et al.
Publicado: (2022)

Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype
por: Huang, Xiaoyan, et al.
Publicado: (2015)

The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models
por: Cleris, Loredana, et al.
Publicado: (2019)

Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience
por: Sepe, Pierangela, et al.
Publicado: (2019)

A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer
por: Reduzzi, Carolina, et al.
Publicado: (2019)

Impact of biospecimens handling on biomarker research in breast cancer
por: De Cecco, Loris, et al.
Publicado: (2009)

Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer
por: Coradini, D, et al.
Publicado: (2001)

Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma(1)
por: Fina, Emanuela, et al.
Publicado: (2016)

In-depth characterization of breast cancer tumor-promoting cell transcriptome by RNA sequencing and microarrays
por: Callari, Maurizio, et al.
Publicado: (2015)

Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy
por: Di Cosimo, Serena, et al.
Publicado: (2019)

Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients
por: Silvestri, Marco, et al.
Publicado: (2021)

Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer
por: Silvestri, Marco, et al.
Publicado: (2022)

Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020)

Intratumor lactate levels reflect HER2 addiction status in HER2‐positive breast cancer
por: Castagnoli, Lorenzo, et al.
Publicado: (2018)

Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods
por: Fina, Emanuela, et al.
Publicado: (2017)

Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data
por: De Cecco, Loris, et al.
Publicado: (2015)

Comparison of Microarray Platforms for Measuring Differential MicroRNA Expression in Paired Normal/Cancer Colon Tissues
por: Callari, Maurizio, et al.
Publicado: (2012)

Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype
por: Capasso, Immacolata, et al.
Publicado: (2014)

Correction: Comparison of Microarray Platforms for Measuring Differential MicroRNA Expression in Paired Normal/Cancer Colon Tissues
por: Callari, Maurizio, et al.
Publicado: (2013)

Editorial: Exploring Cancer Metabolic Reprogramming through Molecular Imaging
por: Podo, Franca, et al.
Publicado: (2017)

Accurate Data Processing Improves the Reliability of Affymetrix Gene Expression Profiles from FFPE Samples
por: Callari, Maurizio, et al.
Publicado: (2014)

Transcriptome of Male Breast Cancer Matched with Germline Profiling Reveals Novel Molecular Subtypes with Possible Clinical Relevance
por: Zelli, Veronica, et al.
Publicado: (2021)

Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts
por: Baroni, S, et al.
Publicado: (2016)

Metabolic Syndrome and Breast Cancer Molecular Subtypes: An Observational Patient Study
por: Ademi-Islami, Dafina, et al.
Publicado: (2022)

Breast Cancer-Initiating Cells: Insights into Novel Treatment Strategies
por: Santilli, Guido, et al.
Publicado: (2011)

hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer
por: Iorio, Jessica, et al.
Publicado: (2018)

The metabolic footprint of aging in mice
por: Houtkooper, Riekelt H., et al.
Publicado: (2011)

Metabolic transformations in breast cancer subtypes
por: Mitra, Devina, et al.
Publicado: (2014)

Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study
por: Akinyemiju, Tomi, et al.
Publicado: (2022)

Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer
por: Reduzzi, Carolina, et al.
Publicado: (2021)

Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
por: Tringali, Cristina, et al.
Publicado: (2014)

The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function
por: Miodini, P, et al.
Publicado: (1999)

The footprint of the ageing stroma in older patients with breast cancer
por: Brouwers, Barbara, et al.
Publicado: (2017)

Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer
por: Iorio, Egidio, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bmqvrcefnulltc7kuvls31j6k2